
The Largest, Most Active Patient Communities
Activate highly engaged patients both in-community and across other channels for precise reach at unprecedented scale.
Reach opted-in patients with chronic and rare conditions
The most effective way to engage 30M+ annual visitors across 60+ communities and 15+ therapeutic areas while they are actively seeking to learn about treatment options.
Don’t see a community for your treatment’s condition?
We’ve partnered with more than 40 leading manufacturers to launch new communities, including for rare disease, oncology, dermatology, neurology, and Spanish language.
On average, members are 50% more likely to engage in specialty care. Forty-five percent indicate that they have discussed treatment with their doctor after seeing an ad in their MyHealthTeam community.
2024 claims analysis of MyHealthTeam community members vs. diagnosed non-members; 2025 MyHealthTeam ad exposure research.
Proximity to patient, power in connection
MyHealthTeam media and advertising solutions provide healthcare marketers unparalleled access to highly engaged patient communities on-site and across the omnichannel ecosystem.
Patient Diagnosis Targeting
Reach patients in communities through hyper-targeted media aligned to specific health needs based on proprietary zero- and first-party data.
Contextual Sponsorship
Activate patients while they engage with medically reviewed content through 100% share-of voice across a condition-specific topic.
Community Extension
Extend community patient reach across the omnichannel ecosystem at scale including TV, social media, audio, and programmatic inventory.
Coordinated HCP Engagement
Drive cross-channel messaging by connecting community members (who are on average 50% more likely to engage in specialty care) with treating HCPs.
Predictive Audience Building
Uncover patients at critical moments in their health journey, including those likely to become non-adherent, for activation in-community and across all other channels.
The power of zero-party data
A game-changer for pharmaceutical marketing, MyHealthTeam data is zero-party, meaning it is voluntarily shared by opted-in consumers in a privacy-compliant manner.
Expand reach to support patient engagement needs
MyHealthTeam helps brands throughout the product lifecycle find ideal patients at critical points in their health journey.
Community Launch
Partner with us to launch a new community where patients can access medically reviewed content and connect with others. We’ve successfully partnered with more than 40 brands to help them exclusively connect with patients actively seeking treatment information. See our full list of communities here.

Patient Education
Empower patients to take action through branded or unbranded articles, videos, virtual experiences, events, and resource centers that drive engagement.

Clinical Trial Recruitment
Surface your trial to those most likely to pass screening based on diagnosis, treatments, and location, leading to higher randomization rates and recruitment success.
Research and Insights
Go beyond traditional research with publishable surveys, social listening, and rapid insights from our opted-in patient communities, providing a deeper understanding of real-world patient experiences and uncovering unmet needs.
Uncover unique patient insights
MyHealthTeam research has been featured at more than 35 leading medical conferences covering health equity, treatment satisfaction, disease burden, and more.
MyHealthTeam
Living With Secondary Progressive Multiple Sclerosis
Understanding the quality-of-life impact of SPMS along with patient desired outcomes can help neurologists develop the most effective approach to treating patients for whom MS is advancing.
MyHealthTeam
Understanding the Debilitating Nature of Narcolepsy in Patients’ Own Words: A Social Listening Analysis
Background Narcolepsy is a rare, chronic hypersomnolence disorder characterized by debilitating symptoms, including excessive daytime sleepiness (EDS), cataplexy, and disrupted nighttime sleep. Symptoms most typically appear during adolescence2; however, previous reports suggest that diagnosis can be complicated by lack of symptom recognition or misdiagnoses and may be delayed by >10 years. Real-world information and experiences […]
MyHealthTeam
Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters
Objective To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy. Background Challenges swallowing oral medications among children have been shown to affect adherence to treatment. This survey is of critical importance for the practicing neurologist, as it addresses issues related to medication formulation availability […]
Interested in conducting your own research?
From rapidly deployed surveys to social listening and deep insights, we help brands better understand their patients.
Customer Testimonials
Recognized as an industry leader
MyHealthTeam is proud of award-winning people, products, and innovations.
Resources
MyHealthTeam
Better Together: Swoop and MyHealthTeam Overview
Combining the power of the largest provider of programmatic health audiences with the largest U.S. patient communities to deliver unparalleled scale and patient engagement.
DTC Marketing
The Rare Disease Marketing Guide: 5 Strategies Every Pharma Marketer Needs To Know for Patient Engagement
R&D in rare diseases has skyrocketed. Thirty percent of today’s R&D pipeline is in rare diseases, and 40 percent of overall pipeline growth since 2013 is due to rare diseases.
MyHealthTeam
Swoop Expands Patient-Centric Engagement with Acquisition of MyHealthTeam, a Leading Opted-In Patient Community in the U.S.
Swoop announces its acquisition of MyHealthTeam, the creator of one of the largest and most highly engaged opted-in patient social networks in the U.S.
